AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Hematopoietic and Lymphatic System Neoplasm

Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention NCT06686108Phase 21 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: Azacitidine (AZA) Days 1 - 5, Decitabine (DAC), Venetoclax Increasing Knowledge and Interest in Cancer Clinical Trials NCT06501040NA1 site📍 Detroit Hayley Thompson · Tests: Web-based Educational Intervention, Questionnaire Administration Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse NCT06928662Phase 1, Phase 21 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Decitabine, Bone Marrow Aspiration, Bone Marrow Biopsy, Chest Radiography, Cytarabine Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial NCT06470971Phase 21 site📍 Columbus Yuanquan Yang · Tests: Anti-PD-L1 Monoclonal Antibody, Anti-PD1 Monoclonal Antibody, Biopsy, Biospecimen Collection, Bone Scan Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810Phase 12 sites📍 Scottsdale📍 Rochester Mayo Clinic · Tests: Axl/Mer/CSF1R Inhibitor Q702, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome NCT06895473Phase 21 site📍 Portland OHSU Knight Cancer Institute · Tests: Biospecimen Collection, Cytarabine, Lumbar Puncture, Methotrexate, Therapeutic Hydrocortisone Wisconsin Ginseng for Decreasing Cancer Related Fatigue NCT06395441Phase 315 sites📍 Albert Lea📍 Bemidji📍 Brainerd Mayo Clinic · Tests: American Ginseng, Placebo Administration, Questionnaire Administration Allo HSCT Using RIC and PTCy for Hematological Diseases NCT05805605Phase 21 site📍 Minneapolis Masonic Cancer Center, University of Minnesota · Tests: Peripheral Blood Stem Cell Transplant, Allopurinol 300 MG, Fludarabine, Cyclophosphamide, Bone Marrow Cell Transplant Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies NCT05887167Phase 11 site📍 Los Angeles Joshua Sasine, MD, PhD · Tests: autologous hematopoietic stem cells added to planned CAR T Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients NCT04314219Phase 31 site📍 Riyadh King Faisal Specialist Hospital & Research Center · Tests: Cyclophosphamide 50mg, Methotrexate Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma NCT06245629n/a1 site📍 Uppsala Uppsala University · Tests: Bortezomib-bendamustine-melphalan Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoietic Cell Transplant Survivors, IMPACT-HCT Trial NCT07052630NA1 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Internet-Based Intervention, Patient Navigation, Best Practice, Survey Administration The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen NCT01890486n/a1 site📍 Winston-Salem Wake Forest University Health Sciences Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies NCT06904066Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: aldesleukin, cyclophosphamide, fludarabine phosphate, Individual Patient TCR-Transduced PBL, TruSight Oncology (TSO) 500 MRD-Guided BCMA/CD3 Bispecific Antibody Treatment After Stem Cell Transplant for Newly Diagnosed Multiple Myeloma NCT07409454Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: anti-BCMA/CD3 bispecific antibody Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM NCT07109323Phase 1, Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: BCMA CART Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome NCT06128070Phase 21 site📍 Duarte City of Hope Medical Center · Tests: Biospecimen Collection, Chest Computed Tomography, Echocardiography, Hematopoietic Cell Transplantation, Methotrexate Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML NCT07500441n/a1 site📍 Beijing Peking University People's Hospital · Tests: Individualized Digital PCR (dPCR) monitoring Collection and Storage of Tissue and Blood Samples From Patients With Cancer NCT02474160n/a140 sites📍 Birmingham📍 Fort Smith📍 Arroyo Grande National Cancer Institute LAO · Tests: Cytology Specimen Collection Procedure CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT NCT03810196NA1 site📍 Philadelphia Children's Hospital of Philadelphia · Tests: CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy NCT06895538Phase 2, Phase 31 site📍 Beijing Peking University First Hospital · Tests: Rabbit Anti-Human T-Lymphocyte Immunoglobulin (ATLG) Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma NCT07356245Phase 21 site📍 Columbus Jonathan Brammer · Tests: Ruxolitinib, Positron emission tomography-computed tomography, Bone Marrow Biopsy, Biopsy Procedure, Biospecimen Collec… Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant NCT04898790NA1 site📍 Omaha University of Nebraska · Tests: CHAMPS-II adapted to adults 60+ years in HCT setting Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies NCT05108519n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Electronic Health Record Review Massage Impact on Sleep in Pediatric Oncology NCT06892158NA2 sites📍 Washington D.C.📍 Philadelphia Children's Hospital of Philadelphia · Tests: Massage therapy, Standard of care Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis NCT06756152Phase 2, Phase 31 site📍 Moscow Federal Research Institute of Pediatric Hematology, Oncolog… · Tests: Conditioning regimen: Treosulfan 42 g/m2/course or total body irradiation 12 Gray/course, Etoposide 60 mg/kg , Fludarab… Genetic Testing for the Prevention of Cancer in American Indian Communities (JUNIPER Trial) NCT06569316NA1 site📍 Scottsdale Mayo Clinic · Tests: Biospecimen Collection, Communication Intervention, Genetic Testing, Survey Administration Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment NCT07306338n/a1 site📍 Los Angeles University of Southern California · Tests: Non-Interventional Study Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCT NCT07689630Phase 31 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: Methotrexate, Anti-CD25 Monoclonal Antibody The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors NCT04551378n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Quality-of-Life Assessment, Survey Administration
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy